PRIX GALIEN USA
The Prix Galien USA is America’s preeminent prize acknowledging the leading-edge of scientific advances in life sciences since 2007
The 2024 Prix Galien USA Award Winners
Best Pharmaceutical Product
PAXLOVID™ - Pfizer Inc.
Best Biotechnology Product
Best Medical Technology
Best Digital Health Solution
Viz HCM™ - Viz.ai
Best Incubator / Accelerator / Equity
Best Startup
- Pentavere
- CervoMed Inc.
Best Product for Rare/Orphan Diseases
KIMMTRAK - Immunocore
Prix Galien USA 2024 Highlights
Prix Galien USA 2024 Laureates
Best Pharmaceutical Product
(l) Pfizer Inc.
Best Biotechnology Product
(l) Toshinori Agatsuma, Daiichi Sankyo & AstraZeneca
Best Product for Rare/Orphan Diseases
(l) Immunocore
Best Best Medical Technology
(l) Joseph M. DeVivo, Butterfly Network
Best Digital Health Solution
(c) Chris Mansi, Viz.ai
Best Incubator/Accelerator/Equity
(l) TMC Innovation
Best Startup
(c) Aaron Leibtag, Pentavere
Submission is a simple, easy process. Watch our short 3-minute video for a complete explanation of your submission from login to submission, dashboard and upload of all required company assets.
The Prix Galien USA Awards Ceremony launched in 2007, first honoring unique medical products, later devices, and finally, individuals who have impacted patient care through innovation. The Awards Ceremony and Dinner is held annually at the New York City Museum of Natural History following the Galien Forum, which launched in New York City in 2010 and has since been held every autumn the Alexandria Center for Life Science – New York City. We award prizes for Best Pharmaceutical Product, Best Biotechnology Product, and Best Medical Technology approved by the FDA in the past five years as well as Best Digital Health Solution, Best Incubator/Accelerator/Equity and best Startup. Up to three prizes may be awarded annually in each of these categories. The prizes are awarded by a prestigious committees including Nobel laureates, industry leaders and other highly distinguished individuals in the health sector. Learn about our charter and selection criteria.
Any team member having worked on a Prix Galien Winning or Prix Galien nominated product or device is considered an alumnus by the Galien Foundation. We encourage our alumni to take an active part in our growing community by telling their stories from challenge to change for the benefit of human health worldwide.
“The Prix Galien is a welcome initiative to stimulate creative research and promote excellence.”
- Barack Obama, President of the United States – 2008
“I welcome you to the annual Prix Galien awards for innovative excellence in biomedical products and health technologies. The awards are among the highest honors in science and commerce.”
- Jimmy Carter, US President
“The Prix Galien is the right event, on the right issue at the right time. I thank the Galien Foundation for bringing us together and for recognizing that a healthier world is a safer world and a more just world.”
- Ban Ki-moon, UN Secretary-General
he Prize boasts an illustrious list of winners who have entered the Galien Foundation Hall of Fame. The winners archive traces the history of innovations benefitting human health since the prize’s inception in France in 1970. It is with pride that the Galien Foundation chronicles and honors the winning teams and encourages individuals having working on breakthrough products, devices and solution to become Foundation members and thus perpetuate the importance of their innovation to the advancement of human health.
The Prize is awarded in 14 countries worldwide. Winners are candidates for the bi-yearly International prize contending with all prize-winning innovations worldwide
The Prix Galien USA Awards committees include up to 13 esteemed leaders in the life sciences from the United States with one international member and one honorary member. Two committees judge three categories each.
JUDGES IN THE CATEGORIES:
Best Pharmaceutical Product, Best Biotechnology Product, and Best Product for Rare/Orphan Diseases:
MICHAEL ROSENBLATT, MD (Committee Chair)
LINDA B. BUCK, PhD
SUE DESMOND-HELLMANN, MD, MPh
LAURIE GLIMCHER, MD
MARY-CLAIRE KING, PhD
ROBERT S. LANGER, MD
CATO T. LAURENCIN, MD, PhD
STEVEN LESTER, MD
STANLEY B. PRUSINER, MD
PHILLIP A. SHARP, PhD
MARC TESSIER-LAVIGNE, PhD
JUDGES IN THE CATEGORIES:
Best Medical Technology, Best Digital Health Solution, Best Incubator / Accelerator / Equity, and Best Startup:
KENNETH C. FRAZIER (Committee Chair)
ROCH DOLIVEUX
DR. MIKAEL DOLSTEN
ALEX GORSKY
PENNY HEATON
SHERI MCCOY
FRANCOIS MAISONROUGE
JOEL S. MARCUS
ELIAS ZERHOUNI
BERNARD POUSSOT (Past Committee Chair)
MEDICAL TECHNOLOGY SUB-COMMITTEE:
This sub-committee pre-screens all applications in the Medical Technology category before submission of the short list
INCUBATOR, ACCELERATOR, EQUITY, SUB-COMMITTEE:
This sub-committee pre-screens all applications in the IAE category before submission of the short list
DIGITAL HEALTH ADVISORY BOARD:
The Digital Health advisory board pre-screens all applications in the Digital Health category before submission of the short list
STARTUP ADVISORY BOARD:
The Start-up advisory board pre-screens all applications in the StartUp category before submission of the short list